Enzo Biochem (ENZ) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Price: $0.31 --0%
Financial Fact:
Cost of product revenues: 3.31M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Financial Fact:
Cost of product revenues: 3.31M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Enzo Biochem (NYSE: ENZ) reported Q4 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $25.7 million versus the consensus estimate of $24.6 million.
For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- JPMorgan Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
